DIRTT ENVIRONMENTAL SOLUTION (DRTT)

CA25490H1064 - Common Stock

0.3343  0 (-0.36%)

After market: 0.2849 -0.05 (-14.78%)

Fundamental Rating

1

Overall DRTT gets a fundamental rating of 1 out of 10. We evaluated DRTT against 43 industry peers in the Building Products industry. Both the profitability and financial health of DRTT have multiple concerns. DRTT is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year DRTT has reported negative net income.
In the past year DRTT has reported a negative cash flow from operations.
In the past 5 years DRTT reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: DRTT reported negative operating cash flow in multiple years.

1.2 Ratios

The profitability ratios for DRTT are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DRTT has a worse Gross Margin (19.67%) than 75.56% of its industry peers.
In the last couple of years the Gross Margin of DRTT has declined.
The Profit Margin and Operating Margin are not available for DRTT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.31%
GM growth 5Y-17.09%

0

2. Health

2.1 Basic Checks

DRTT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DRTT has more shares outstanding
DRTT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DRTT has a worse debt to assets ratio.

2.2 Solvency

DRTT has an Altman-Z score of -1.12. This is a bad value and indicates that DRTT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.12, DRTT is doing worse than 93.33% of the companies in the same industry.
A Debt/Equity ratio of 8.35 is on the high side and indicates that DRTT has dependencies on debt financing.
The Debt to Equity ratio of DRTT (8.35) is worse than 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.35
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACC8.43%

2.3 Liquidity

A Current Ratio of 1.51 indicates that DRTT should not have too much problems paying its short term obligations.
The Current ratio of DRTT (1.51) is worse than 82.22% of its industry peers.
DRTT has a Quick Ratio of 1.51. This is a bad value and indicates that DRTT is not financially healthy enough and could expect problems in meeting its short term obligations.
DRTT has a worse Quick ratio (0.89) than 82.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 0.89

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.97% over the past year.
Looking at the last year, DRTT shows a quite strong growth in Revenue. The Revenue has grown by 9.06% in the last year.
Measured over the past years, DRTT shows a decrease in Revenue. The Revenue has been decreasing by -5.31% on average per year.
EPS 1Y (TTM)35.97%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q55.56%
Revenue 1Y (TTM)9.06%
Revenue growth 3Y-11.42%
Revenue growth 5Y-5.31%
Revenue growth Q2Q-4.12%

3.2 Future

Based on estimates for the next years, DRTT will show a very strong growth in Earnings Per Share. The EPS will grow by 35.11% on average per year.
Based on estimates for the next years, DRTT will show a small growth in Revenue. The Revenue will grow by 2.38% on average per year.
EPS Next Y65.08%
EPS Next 2Y35.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.82%
Revenue Next 2Y2.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DRTT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DRTT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as DRTT's earnings are expected to grow with 35.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.11%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

DRTT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DIRTT ENVIRONMENTAL SOLUTION

NASDAQ:DRTT (9/14/2023, 8:21:28 PM)

After market: 0.2849 -0.05 (-14.78%)

0.3343

0 (-0.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap34.92M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.67%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 8.35
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.51
Quick Ratio 0.89
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)35.97%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y65.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)9.06%
Revenue growth 3Y-11.42%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y